At a glance
- Originator AnorMED
- Class Antibacterials; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 09 Dec 1997 Discontinued-Preclinical for Bacterial infections in Canada (Unknown route)